Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment

Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment

BackgroundSubjective cognitive impairment (SCI) is common after acute ischemic stroke and adversely affects the quality of life. SCI is associated with an increased risk of developing mild cognitive impairment and dementia. Identifying biomarkers which could predict long-term cognitive outcomes of p...

Full description

Bibliographic Details
Main Authors:	Jian-Hong Wang, Jie Huang, Fu-Qiang Guo, Fang Wang, Shu Yang, Neng-Wei Yu, Bo Zheng, Jian Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Aging Neuroscience
Subjects:	acute ischemic stroke neurofilament light biomarker prognosis subjective cognitive impairment (SCI)
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.665981/full

Similar Items

Plasma Neurofilament Light Chain as a Predictive Biomarker for Post-stroke Cognitive Impairment: A Prospective Cohort Study
by: Zhiqiang Wang, et al.
Published: (2021-02-01)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
by: Yi Chen, et al.
Published: (2021-12-01)

The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease
by: Yi-Chou Hou, et al.
Published: (2021-05-01)

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum
by: Sylvain Lehmann, et al.
Published: (2023-12-01)

Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study
by: Kunal Dhiman, et al.
Published: (2022-04-01)

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition
by: Katie E. Osborn, et al.
Published: (2019-12-01)

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer’s Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration
by: Shreyasee Das, et al.
Published: (2022-06-01)

Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis
by: Zhenyi Fan, et al.
Published: (2023-06-01)

Association Between Serum Neurofilament Light Chain and Cognitive Performance Among Older Adults in the United States: A Cross-Sectional Study
by: Yuanyuan Gao, et al.
Published: (2023-10-01)

Association Between Pre-Stroke Subjective Sleep Status and Post-Stroke Cognitive Impairment: A Nationwide Multi-Center Prospective Registry
by: Zhang JL, et al.
Published: (2022-11-01)

Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
by: Jan Traub, et al.
Published: (2022-10-01)

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
by: Nerea Requena-Ocaña, et al.
Published: (2023-01-01)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
by: Yumei Liu, et al.
Published: (2022-09-01)

A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment
by: Adele E. Cave, et al.
Published: (2023-08-01)

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia
by: Christina Hoyer-Kimura, et al.
Published: (2021-10-01)

Serum neurofilament light chain levels are associated with early neurological deterioration in minor ischemic stroke
by: Jie Li, et al.
Published: (2023-03-01)

Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain
by: Cynthia Yi-an Chen, et al.
Published: (2024-04-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
by: Pia Kivisäkk, et al.
Published: (2023-03-01)

Predictive value of serum neurofilament light chain for persistent cognitive deficits in elderly depressive patients
by: Christoph Linnemann, et al.
Published: (2021-04-01)

Shedding light on neurofilament involvement in cognitive decline in obstructive sleep apnea and its possible role as a biomarker
by: Julia Jaromirska, et al.
Published: (2023-11-01)

Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients
by: Huțanu Adina, et al.
Published: (2018-01-01)

Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults
by: Lingxiao He, et al.
Published: (2020-10-01)

Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke
by: Xiaoting Zhang, et al.
Published: (2022-07-01)

A new marker for ischemic cerebrovascular stroke: Phosphorylated Neurofilament H
by: Waheed M. Radwan, et al.
Published: (2013-04-01)

Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy
by: Zhang Q, et al.
Published: (2023-01-01)

Does serum neurofilament light help predict accelerated cognitive ageing in unimpaired older adults?
by: Jessica M. Collins, et al.
Published: (2023-08-01)

Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome
by: Chung-Hsin Wu, et al.
Published: (2023-09-01)

Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis
by: Vlad Eugen Tiu, et al.
Published: (2022-10-01)

Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia
by: Magnus Johnsson, et al.
Published: (2024-01-01)

Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye
by: Jianhao Bai, et al.
Published: (2022-11-01)

Vision impairment, hearing impairment and functional Limitations of subjective cognitive decline: a population-based study
by: Ruirui Guo, et al.
Published: (2023-04-01)

Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial
by: Adele E. Cave, et al.
Published: (2019-06-01)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01)

Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates
by: Chiara Gallingani, et al.
Published: (2024-03-01)

Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
by: Isabella Zanella, et al.
Published: (2022-05-01)

Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
by: Hongge Wang, et al.
Published: (2022-03-01)

Serum neurofilament light chain level as a predictor of cognitive stage transition
by: Eun-Hye Lee, et al.
Published: (2022-01-01)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
by: Lin JB, et al.
Published: (2023-08-01)

Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish
by: Doris Lou Demy, et al.
Published: (2020-05-01)

Raised Plasma Neurofilament Light Protein Levels After Rewarming Are Associated With Adverse Neurodevelopmental Outcomes in Newborns After Therapeutic Hypothermia
by: Divyen K. Shah, et al.
Published: (2020-10-01)